Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist

Published:2017-02-07 Issue:1 Volume:12 Page:
ISSN:1750-9378
Container-title:Infectious Agents and Cancer
language:en
Short-container-title:Infect Agents Cancer

Author:

Nappi A.,Perrella A.,Bellopede P.,Lanza A.,Izzi A.,Spatarella M.,Sbreglia C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Infectious Diseases,Oncology,Epidemiology

Link

http://link.springer.com/content/pdf/10.1186/s13027-017-0119-8.pdf

Reference16 articles.

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42.

2. Armstrong GL, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705–14.

3. WHO. Hepatitis C. < http://www.who.int/mediacentre/factsheets/fs164/en/ >. Accessed 2 July 2015.

4. Ghany MG, et al. American association for the study of liver diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2011;49(4):1335–74.

5. Esteban JI, Sauleda S, Quer J. Changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008;48:148–62.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A therapeutic approach for the hepatitis C virus: in silico design of an antisense oligonucleotide-based candidate capsid inhibitor;Virus Genes;2024-07-31

2. Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020;Journal of Clinical Medicine;2021-12-29

3. Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?;European Journal of Hospital Pharmacy;2019-06-14

4. Tolerability and effectiveness of generic direct‐acting antiviral drugs in eradication of hepatitis C genotype 4 among Egyptian patients;Liver International;2019-02-06

5. Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case Presentation;Current Drug Safety;2019-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3